Navigation Links
Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
Date:8/25/2009

RIDGEFIELD, Conn., Aug. 25 /PRNewswire/ -- Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran)(1) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).(1)

Atrial fibrillation affects approximately 2.3 million Americans(2) and can increase the risk of stroke five-fold.(3) Top-line findings from the 18,113 patient RE-LY study(1) will be featured in an ESC press briefing on Sunday, Aug. 30 at 8:00 a.m. CEST, with the full results presented in a "Hot-Line" session at 11:00 a.m. CEST. The study will also be simultaneously published in a leading peer-reviewed medical journal.

Dabigatran etexilate is an investigational oral anticoagulant in Phase III development for stroke prevention in AF(1) and several other therapeutic areas, including prevention of atherothrombotic events in patients with acute coronary syndrome,(4) as well as primary prevention, (5),(6),(7) secondary prevention(8) and treatment of venous thromboembolism.(9) Dabigatran etexilate is not yet approved by the U.S. Food and Drug Administration.

In addition to the primary findings, a RE-LY sub-analysis of treatment naive patients will also be presented during a "Clinical Trial Update" session on Wednesday, Sept. 2 at 8:00 a.m. CEST.

About RE-LY: The largest AF outcomes trial to date

RE-LY was a global, Phase III, randomized trial of 18,113 patients(1) enrolled in more than 900 centers in 44 countries,(1) investigating whether dabigatran etexilate (two blinded doses) was as effective as well-con
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
2. PSA Screening Cuts Deaths by 20%, Says Worlds Largest Prostate Cancer Study
3. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
4. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
5. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
6. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
7. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
8. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
9. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
10. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
11. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... YORK , May 22, 2013 ... investigating potential claims on behalf of purchasers of ... the "Company") (NasdaqGS: AMAG -News).  The investigation focuses ... federal securities laws. On May 22, ... during intraday trading after the company announced in ...
(Date:5/22/2013)... WHITE PLAINS, N.Y. , May 22, 2013 /PRNewswire/ ... $6 million to Valor Biotherapeutics, LLC, a ... completion of pre-clinical development, manufacturing, and a Phase I ... change the poor outcomes faced by many patients with ... with rituximab. Valor,s protein, IGN002, is ...
(Date:5/22/2013)... NEW YORK , May 22, 2013  The ... international conference devoted to advancing new treatments for lupus ... to 60 percent of patients. The conference launched a ... – the Lupus Nephritis Trials Network (LNTN). ... lupus and the kidney came together to focus on ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2
... N.J., Sept. 29 Sparta Systems, Inc. ... software and the market leader in enterprise ... Qualitest Pharmaceuticals , a top-six provider of ... streamline multiple quality and compliance processes.   ...
... China, Sept. 29 /PRNewswire-Asia-FirstCall/ -- ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
Cached Medicine Technology:Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management 2Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management 3Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management 4Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 2Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 3Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 4Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 5Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 6Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 7Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 8Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 9
(Date:5/22/2013)... Researchers in genomic health disparities from the University ... University School of Medicine have teamed up to hold ... Eliminate Health Disparities in Genomic Medicine." The theme ... nonprofits, business and government to reduce these disparities. , ... United States, individuals within underserved groups continue to be ...
(Date:5/22/2013)... By Maureen Salamon HealthDay Reporter , , WEDNESDAY, ... each cause a great deal of suffering, but new ... linked to something else entirely -- a smaller brain. ... double the risk of depression, scientists wanted to determine ... The difference in size -- about 2 percent -- ...
(Date:5/22/2013)... 22, 2013 Award Presented at the ... press release here: http://bit.ly/13DkFfk , Merrill Corporation ... “Information Management Product/Service of the Year” at the 7th ... The Colony Hotel in Palm Beach, Florida. , ... room (VDR) solution that optimizes the due diligence ...
(Date:5/22/2013)... May 22, 2013 Recent tragedies ... and the school shooting in Newtown, Connecticut all ... , Emergency medical practitioners train to ... the Emergency Medical Services for Children (EMSC) Program ... care for the youngest patients. It is estimated ...
(Date:5/22/2013)... Registered Dietitian and Founder of Tatalou Science ... sharing a recipe for making energy bars at home. , ... ,” takes a recipe modified from one recently featured ... day it gets more and more difficult to understand what ... size of the nutrition label continues to grow and consumers ...
Breaking Medicine News(10 mins):Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:How To "Make Your Own Healthy Energy Bars" 2
... FRIDAY, Oct. 1 (HealthDay News) -- A good night,s ... levels normal, new research suggests. Pregnant women who got ... had systolic blood pressure readings in their last trimester that ... hours nightly, the study found. And women who got less ...
... 1, 2010 A UC Irvine infectious disease specialist has ... of new methods to prevent staph infections in people who ... The federal Agency for Healthcare Research & Quality awarded Huang ... funded by American Recovery & Reinvestment Act of 2009. CHOICE ...
... (Oct.. 1, 2010)"It,s Your Game: Keep It Real," an evidence-based ... Texas Health Science Center at Houston (UTHealth), will be implemented ... part of a federally-funded program to tackle the U.S. teenage ... Human Services (HHS) awarded $15 million of its $155-million total ...
... a University of California, Berkeley, researcher could give women a ... study suggests that women who get dental care reduce their ... at least one-third. The analysis, which used data ... and Retirement Study, did not find a similar benefit for ...
... , THURSDAY, Sept. 30 (HealthDay News) -- New research finds ... soon as levels of a biomarker for the cancer rise ... begin to reappear. Blood levels of the marker, known ... ovarian cancer relapse, but there has been some debate on ...
... of the journal Sleep found that getting too little ... blood pressure in the third trimester. The study suggests that ... show that the mean systolic blood pressure in the third trimester ... sleep duration of nine hours in early pregnancy, 118.05 mm Hg ...
Cached Medicine News:Health News:Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure 2Health News:Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure 3Health News:UCI gets major funding to study ways of preventing drug-resistant staph infections 2Health News:UTHealth researchers awarded $15 million for teen pregnancy prevention 2Health News:Women who get dental care have lower risk of heart disease, says study 2Health News:Women who get dental care have lower risk of heart disease, says study 3Health News:New Clues to Treating Ovarian Cancer Relapse 2Health News:New Clues to Treating Ovarian Cancer Relapse 3Health News:Short and long sleep in early pregnancy linked to high blood pressure in the third trimester 2Health News:Short and long sleep in early pregnancy linked to high blood pressure in the third trimester 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: